3. Exclusion: Not meeting criteria for CML, other MPNs, or myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangements (e.g., PDGFRA, PDGFRB, FGFR1, JAK2). This evidence concerns the gene JAK2 and Increased total eosinophil count.